Englander Institute for Precision Medicine

Publications

Found 805 results
Author Title Type [ Year(Asc)]
2025
Yoffe L, Bhinder B, Kang SWook, Zhang H, Singh A, Ravichandran H, Markowitz G, Martin M, Kim J, Zhang C et al..  2025.  Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer.. bioRxiv.
Setzen SA, Andreadis K, Elemento O, Rameau A.  2025.  AI-Powered Laryngoscopy: Exploring the Future With Google Gemini.. Laryngoscope.
O'Boyle B, Yeung W, Lu JD, Katiyar S, Yaron-Barir TM, Johnson JL, Cantley LC, Kannan N.  2025.  An atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.. Sci Signal. 18(885):eadt8686.
Gao VR, Yang R, Das A, Luo R, Luo H, McNally DR, Karagiannidis I, Rivas MA, Wang Z-M, Barisic D et al..  2025.  Author Correction: ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.. Nat Commun. 16(1):684.
Khosravi P, Saikali S, Alipour A, Mohammadi S, Boger M, Diallo DM, Smith CJ, Moschovas MC, Hajirasouliha I, Hung AJ et al..  2025.  AutoRadAI: a versatile artificial intelligence framework validated for detecting extracapsular extension in prostate cancer.. Biol Methods Protoc. 10(1):bpaf032.
Bellmunt J, Powles T, Park SHoon, Voog E, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N et al..  2025.  Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node-only Disease.. Eur Urol.
Moothedan E, Boyer M, Watts S, Abdel-Aty Y, Ghosh S, Rameau A, Sigaras A, Elemento O, Bensoussan Y.  2025.  The Bridge2AI-voice application: initial feasibility study of voice data acquisition through mobile health.. Front Digit Health. 7:1514971.
Borea R, Saldanha EF, Maheswaran S, Nicolo E, Singhal S, Pontolillo L, Perez Dde Miguel, Venetis K, Dipasquale A, Ghazali N et al..  2025.  Cancer in a drop: Advances in liquid biopsy in 2024.. Crit Rev Oncol Hematol. 213:104776.
Teng M, Guo J, Xu X, Ci X, Mo Y, Kohen Y, Ni Z, Chen S, Guo WYuan, Bakht M et al..  2025.  Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.. Cancer Cell.
Kadri S, Craven KE, Fussell AM, Gee EPS, Jordan D, Klee EW, Krumm N, Temple-Smolkin RL, Zehir A, Zhang W et al..  2025.  Clinical Bioinformatician Body of Knowledge-Bioinformatics and Software Core: A Report of the Association for Molecular Pathology.. J Mol Diagn.
Agarwal PK, Sternberg CN.  2025.  Clinical trials corner issue 11(1).. Bladder Cancer. 11(1):23523735241309418.
Nauseef JT, Chu TR, Hooper WF, Alonso A, Oku A, Geiger H, Goldstein ZR, Shah M, Sigouros M, Manohar J et al..  2025.  A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.. NPJ Precis Oncol. 9(1):91.
Müller-Dott S, Jaehnig EJ, Munchic KPham, Jiang W, Yaron-Barir TM, Savage SR, Garrido-Rodriguez M, Johnson JL, Lussana A, Petsalaki E et al..  2025.  Comprehensive evaluation of phosphoproteomic-based kinase activity inference.. Nat Commun. 16(1):4771.
Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K et al..  2025.  Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.. Commun Med (Lond). 5(1):11.
Chew SMei, Teumer A, Matías-García PR, Gieger C, Winckelmann J, Suhre K, Herder C, Rathmann W, Peters A, Waldenberger M.  2025.  Cross-sectional and longitudinal association of seven DNAm-based predictors with metabolic syndrome and type 2 diabetes.. Clin Epigenetics. 17(1):58.
Jiang W, Jaehnig EJ, Liao Y, Shi Z, Yaron-Barir TM, Johnson JL, Cantley LC, Zhang B.  2025.  Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites.. Nat Commun. 16(1):2766.
Kim YE, Dobko M, Li H, Shao T, Periyakoil P, Tipton C, Colasacco C, Serpedin A, Elemento O, Sabuncu M et al..  2025.  A Deep-Learning Model for Multi-class Audio Classification of Vocal Fold Pathologies in Office Stroboscopy.. Laryngoscope.
Tian Y, Bhattacharya R, Yoo S, Jiang F, Park E, Granados GLara, Shen Y, Park K-S, Kaniskan HUmit, Jin J et al..  2025.  Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma.. iScience. 28(5):112387.
Cheng APellan, Widman AJ, Arora A, Rusinek I, Sossin A, Rajagopalan S, Midler N, Hooper WF, Murray RM, Halmos D et al..  2025.  Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling.. Nat Methods.
de Bono JS, He M, Shi Z, Nowicka M, Bracarda S, Sternberg CN, Chi KN, Olmos D, Sandhu S, Massard C et al..  2025.  Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial.. Eur Urol.
Claridge SE, Nath S, Baum A, Farias R, Cavallo J-A, Rizvi NM, De Boni L, Park E, Granados GLara, Hauesgen M et al..  2025.  Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer.. Clin Transl Med. 15(2):e70078.
Borea R, Reduzzi C.  2025.  The growing field of liquid biopsy and its Snowball effect on reshaping cancer management.. J Liq Biopsy. 8:100293.
Barton BM, Son F, Verma A, Bal SKumar, Tang Q, Wang R, Umphred-Wilson K, Khan R, Trichka J, Dong H et al..  2025.  IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs.. Nat Immunol.
Rowdo FPMadorsky, Martini R, Ackermann SE, Tang CP, Tranquille M, Irizarry A, Us I, Alawa O, Moyer JE, Sigouros M et al..  2025.  Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.. Cancer Res. 85(3):551-566.
Howlader MJ, Rashighi M, Santambrogio L, Lu TT.  2025.  Lymphatic messengers: Non-antigen soluble mediators from diseased tissues to draining lymph nodes.. Curr Opin Immunol. 93:102536.